HomeCompareMKEAF vs EPRT

MKEAF vs EPRT: Dividend Comparison 2026

MKEAF yields 540.54% · EPRT yields 3.97%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MKEAF wins by $112786.16M in total portfolio value
10 years
MKEAF
MKEAF
● Live price
540.54%
Share price
$0.37
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$112786.22M
Annual income
$82,692,515,806.61
Full MKEAF calculator →
EPRT
EPRT
● Live price
3.97%
Share price
$30.36
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$64.3K
Annual income
$13,170.85
Full EPRT calculator →

Portfolio growth — MKEAF vs EPRT

📍 MKEAF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMKEAFEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MKEAF + EPRT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MKEAF pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MKEAF
Annual income on $10K today (after 15% tax)
$45,945.95/yr
After 10yr DRIP, annual income (after tax)
$70,288,638,435.62/yr
EPRT
Annual income on $10K today (after 15% tax)
$337.37/yr
After 10yr DRIP, annual income (after tax)
$11,195.22/yr
At 15% tax rate, MKEAF beats the other by $70,288,627,240.40/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MKEAF + EPRT for your $10,000?

MKEAF: 50%EPRT: 50%
100% EPRT50/50100% MKEAF
Portfolio after 10yr
$56393.14M
Annual income
$41,346,264,488.74/yr
Blended yield
73.32%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

MKEAF
No analyst data
Altman Z
-4.4
Piotroski
4/9
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+16.9% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MKEAF buys
0
EPRT buys
0
No recent congressional trades found for MKEAF or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMKEAFEPRT
Forward yield540.54%3.97%
Annual dividend / share$2.00$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%29%
Portfolio after 10y$112786.22M$64.3K
Annual income after 10y$82,692,515,806.61$13,170.85
Total dividends collected$110217.05M$38.7K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: MKEAF vs EPRT ($10,000, DRIP)

YearMKEAF PortfolioMKEAF Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$64,754$54,054.05$11,212$512.01+$53.5KMKEAF
2$396,410$327,123.28$12,689$692.09+$383.7KMKEAF
3$2,295,726$1,871,567.31$14,521$944.30+$2.28MMKEAF
4$12,586,137$10,129,710.14$16,841$1,302.88+$12.57MMKEAF
5$65,369,349$51,902,182.37$19,841$1,821.64+$65.35MMKEAF
6$321,877,325$251,932,121.38$23,818$2,587.47+$321.85MMKEAF
7$1,503,762,535$1,159,353,797.14$29,230$3,744.65+$1503.73MMKEAF
8$6,671,013,644$5,061,987,731.83$36,816$5,540.38+$6670.98MMKEAF
9$28,124,961,234$20,986,976,635.20$47,806$8,413.17+$28124.91MMKEAF
10$112,786,224,327$82,692,515,806.61$64,324$13,170.85+$112786.16MMKEAF

MKEAF vs EPRT: Complete Analysis 2026

MKEAFStock

Mauna Kea Technologies SA develops and markets medical devices in Europe, the Middle East, Africa, the United States, Latin America, and Asia. The company designs, develops, and markets tools to visualize and detect cell abnormalities in real time during standard gastrointestinal and pulmonary endoscopy procedures. Its flagship product is Cellvizio, a confocal miniprobe endomicroscopy system which provides physicians and researchers high-resolution images of tissues at the cellular level. The company was incorporated in 2000 and is headquartered in Paris, France.

Full MKEAF Calculator →

EPRTREIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this MKEAF vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MKEAF vs SCHDMKEAF vs JEPIMKEAF vs OMKEAF vs KOMKEAF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.